Marvin & Palmer Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$3.76M |
| 2 |
Baker Hughes
BKR
|
+$3.56M |
| 3 |
Valero Energy
VLO
|
+$3.34M |
| 4 |
NextEra Energy
NEE
|
+$3.26M |
| 5 |
Deere & Co
DE
|
+$3.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$9.13M |
| 2 |
Morgan Stanley
MS
|
+$9.02M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$6.75M |
| 4 |
Goldman Sachs
GS
|
+$5.86M |
| 5 |
Citigroup
C
|
+$5.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 28.32% |
| 2 | Technology | 24.15% |
| 3 | Energy | 13.49% |
| 4 | Financials | 8.87% |
| 5 | Consumer Discretionary | 4.46% |
No holdings matched the selected filter criteria.
Similar funds
Marvin & Palmer Associates's Q1 2026 Portfolio in Review
As of Q1 2026, Marvin & Palmer Associates held 33 positions worth $83.5M, down 41% from $142M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Marvin & Palmer Associates withdrew a net $60.9M in Q1 2026, closing 12 positions and reducing 12 holdings. Its most notable exit was Broadcom, an estimated $9.13M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 28% of assets, up from 9.7% a quarter earlier, followed by Technology and Energy.
Against the trend, Marvin & Palmer Associates opened a new position in Ametek worth $3.63M.
- Marvin & Palmer Associates's largest Q1 2026 buy was Ametek: 16,917 shares worth $3.63M.
- Marvin & Palmer Associates added most to State Street SPDR S&P Biotech ETF in Q1 2026, an estimated $399K increase.
- Marvin & Palmer Associates's biggest Q1 2026 reduction was Goldman Sachs, cutting an estimated $5.86M.
- Marvin & Palmer Associates fully exited Broadcom in Q1 2026, selling an estimated $9.13M.
- Marvin & Palmer Associates's ten largest holdings make up 56% of its $83.5M portfolio in Q1 2026.
- Marvin & Palmer Associates opened 6 new positions and closed 12 in Q1 2026.
- Marvin & Palmer Associates's portfolio value fell 41% quarter-over-quarter to $83.5M.
Based on Marvin & Palmer Associates's 13F filing for Q1 2026, filed 8 May 2026.